SCIENTIFIC HUB

Follow the evidence.

191.038 articles found

Open access

NLX-112 Randomized Phase 2A Trial: Safety, Tolerability, Anti-Dyskinetic, and Anti-Parkinsonian Efficacy.

Svenningsson P, Odin P, Bergquist F, Wirdefeldt K, Nyholm D, Andréasson M, Markaki I, Johansson AC, Jergil M, Jankosky C, Varney MA, Herbrecht F, Johnson SA, Newman-Tancredi A.

Mov Disord · 2025-03-17

DOI: 10.1002/mds.30175PMID: 40091754

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Deep Learning-Based Artificial Intelligence Algorithm to Classify Tremors from Hand-Drawn Spirals.

Anandapadmanabhan R, Vishnoi A, Raman G, Thachan J, Gangaraju BA, Radhakrishnan D, Vishnu VY, Kamble N, Holla V, James P, Srivastava A, Joshi D, Mahabal A, Krishnan S, Kumar Pal P, Rajan R.

Mov Disord · 2025-03-17

DOI: 10.1002/mds.30176PMID: 40095435

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

Apigenin enhances Nrf2-induced chaperone-mediated autophagy and mitigates α-synuclein pathology: Implications for Parkinson's disease therapy.

Huang YB, Tian LL, Zhu ZW, Zhou KG, Lai X, Peng YZ, Wu Z, Tong WF, Wang H, Wang XJ, Guan Q, Jin LJ, Feng Y, Weng WY, Zhang JX.

Phytomedicine · 2025-03-17

DOI: 10.1016/j.phymed.2025.156652PMID: 40215824

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.